Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A7 | Q99884 | 1/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.50 |
| ▸ | NAMPT | P43490 | 2/20 | 0.46 |
| ▸ | FASN | P49327 | 5/20 | 0.45 |
| ▸ | GRM5 | P41594 | 2/20 | 0.43 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27702525 | 0.82 | SLC6A7 (0.63) | SLC6A7TRPV1NAMPTGRM5RIPK1 | |
| SCHEMBL4813898 | 0.80 | SLC6A7 (0.66) | SLC6A7TRPV1NAMPTGRM5RIPK1 | |
| SCHEMBL937088 | 0.76 | FASN (0.44) | FASNKDM4E | |
| SCHEMBL2011822 | 0.75 | SLC6A7 (0.56) | SLC6A7TRPV1NAMPTGRM5RIPK1 | |
| SCHEMBL9557855 | 0.73 | SLC6A7 (0.52) | SLC6A7TRPV1NAMPTGRM5RIPK1 | |
| SCHEMBL24962294 | 0.72 | SLC6A7 (0.50) | SLC6A7TRPV1NAMPTGRM5RIPK1 | |
| SCHEMBL5317665 | 0.72 | SLC6A7 (0.53) | SLC6A7TRPV1NAMPTRIPK1KDM4E | |
| SCHEMBL5317667 | 0.72 | SLC6A7 (0.53) | SLC6A7TRPV1NAMPTRIPK1KDM4E | |
| SCHEMBL29473497 | 0.72 | TRPV1 (0.57) | SLC6A7TRPV1ALDH1A1 | |
| SCHEMBL939343 | 0.72 | TRPV1 (0.54) | SLC6A7TRPV1NAMPTGRM5RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2257291-A2 | PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS | Xenon Pharmaceuticals Inc. (CA) | 2010-12-08 | — | — | EP | disclosed |
| WO-2009106991-A2 | PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2009-09-03 | — | — | WO | disclosed |
| EP-1851205-A2 | PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2007-11-07 | — | — | EP | disclosed |
| WO-2006086447-A2 | PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2006-08-17 | — | — | WO | disclosed |